Holistic Botanicals · Complete Reference

Immune & Anti-Cancer Botanicals

A practitioner-level reference covering plant medicines used to modulate immune function, support oncology care, enhance NK cell activity, and target cancer-associated pathways — with dosing, mechanisms, and clinical context.

Important clinical note: Anti-cancer botanicals are integrative adjuncts — not replacements for conventional oncology care. Several compounds interact with chemotherapy and radiation. Always disclose all botanicals to the treating oncologist before use in active cancer treatment.

Astragalus (Astragalus membranaceus)

Key Compounds: Astragalosides (I–IV), cycloastragenol, polysaccharides (APS)

Mechanism: Astragalus polysaccharides activate macrophages, NK cells, and T-lymphocytes, upregulating immune surveillance. Cycloastragenol activates telomerase, supporting telomere length and cellular longevity. Demonstrated to counteract chemotherapy-induced immunosuppression in multiple clinical trials and improve quality of life in cancer patients.

Applications: Immune deficiency, chemotherapy support (between cycles), chronic infection, viral susceptibility, telomere support, general adaptogenic tonic.

Dosing: Standardized extract (0.5% astragalosides): 400–800 mg 2–3× daily. Root powder: 2–6g/day. Injectable forms (IV) used in clinical oncology settings.

Cycling: Suitable for long-term use as a tonic. In oncology context: use between chemo cycles, not during active cytotoxic treatment (discuss timing with oncologist).

Cautions: May stimulate autoimmune activity — caution in autoimmune disease. Avoid during active immunosuppressive therapy. Do not use during active chemo without oncologist approval.

Cat's Claw (Uncaria tomentosa)

Key Compounds: Oxindole alkaloids (isopteropodin, mitraphylline), quinovic acid glycosides, proanthocyanidins

Mechanism: Oxindole alkaloids modulate NF-κB activity, inhibit TNF-α production, and enhance phagocytic activity of macrophages and granulocytes. Demonstrates DNA repair support and anti-mutagenic properties in vitro. Used in Lyme disease protocols for immune modulation and co-infection support.

Applications: Immune modulation, Lyme disease adjunct, inflammatory conditions, DNA repair support, viral chronic infections, cancer adjunct research.

Dosing: TOA-free extract: 20–60 mg alkaloids/day (preferred for immune use). Standard extract: 300–500 mg 3× daily. Tincture: 2–4 mL 3× daily.

Cycling: 4–8 weeks on / 2 weeks off. Long-term use possible with periodic breaks.

Cautions: Avoid in pregnancy and autoimmune disease without supervision. May interact with anticoagulants and immunosuppressants. Use TOA-free forms for immune-stimulating effects.

Elderberry (Sambucus nigra)

Key Compounds: Anthocyanins (cyanidin-3-glucoside, cyanidin-3-sambubioside), flavonoids, lectins

Mechanism: Elderberry lectins and anthocyanins inhibit viral hemagglutinin — the surface protein viruses use to bind and enter host cells. Also stimulates cytokine production (IL-1β, TNF-α, IL-6, IL-8) for acute immune activation. Clinical trials show significant reduction in duration and severity of influenza and cold symptoms.

Applications: Acute viral infections (influenza, RSV, common cold), immune priming, antioxidant support.

Dosing: Standardized extract (3.2% anthocyanins): 175–350 mg 2× daily. Syrup: 1 tbsp 4× daily during acute illness. Gummies/lozenges: per product standardization.

Cycling: Acute use: 5–7 days at therapeutic dose. Preventive: lower dose seasonally. Avoid continuous high-dose use in autoimmune conditions.

Cautions: Cytokine-stimulating effect — use with caution in autoimmune disease and cytokine storm risk (avoid in active COVID severe phase). Raw elderberries contain sambunigrin (toxic) — always use cooked or standardized preparations.

Turkey Tail (Trametes versicolor)

Key Compounds: PSK (polysaccharide-K, Krestin), PSP (polysaccharide-peptide)

Mechanism: PSK is one of the most studied anti-cancer compounds in the world — approved as an oncology adjunct drug in Japan. Activates NK cells, dendritic cells, and cytotoxic T lymphocytes. PSP demonstrates direct anti-tumor activity and microbiome-supportive effects. Clinical evidence for improved survival in colorectal, gastric, and breast cancer when combined with conventional treatment.

Applications: Cancer adjunct (post-surgery, during/after chemo), immune recovery, microbiome restoration, HPV clearance support.

Dosing: PSK extract: 3g/day (oncology dose used in Japanese trials). Hot-water extract powder: 2–4g/day. Dual-extract: 500–1,000 mg 2–3× daily.

Cycling: Continuous use appropriate in oncology context under supervision. General immune use: 3 months on / 1 month off.

Cautions: Very well tolerated. Rare GI upset. Confirm hot-water extraction (cold ethanol extracts miss polysaccharide content). Quality sourcing critical.

Reishi (Ganoderma lucidum)

Key Compounds: Ganoderic acids (triterpenoids), beta-glucans, polysaccharides

Mechanism: Ganoderic acids inhibit histamine release (anti-allergic), suppress NF-κB and AP-1 inflammatory signaling, and modulate Th1/Th2 immune balance. Beta-glucans activate macrophages and NK cells. Demonstrated anti-tumor activity via induction of apoptosis and inhibition of angiogenesis. Also adaptogenic and hepatoprotective.

Applications: Cancer adjunct, autoimmune modulation, chronic fatigue, liver protection, anxiety, sleep, allergic conditions, viral infections.

Dosing: Dual-extract (hot water + ethanol): 1,000–3,000 mg/day. Spore oil: 500–1,000 mg/day (highest triterpene concentration). Decoction: 1–2g dried mushroom simmered 30+ min.

Cycling: Can be used continuously at tonic doses. Higher therapeutic doses: 3 months on / 1 month off.

Cautions: May thin blood — caution with anticoagulants. Possible dry mouth, dizziness at high doses. Ensure dual-extraction for full-spectrum activity.

Mistletoe Extract (Viscum album — Iscador, Helixor, Iscucin)

Key Compounds: Viscotoxins, lectins (ML-I, ML-II, ML-III)

Mechanism: Mistletoe lectins induce apoptosis in tumor cells, stimulate NK cell and cytotoxic T-cell activity, and demonstrate direct cytotoxicity against multiple cancer cell lines. Also reduces chemotherapy side effects and improves quality of life. Used as subcutaneous injection (IV in clinical settings) in European integrative oncology.

Applications: Cancer adjunct therapy (most tumor types studied), chemotherapy side effect reduction, quality of life, immune restoration post-treatment.

Dosing: Subcutaneous injection (clinical): dose-titrated by practitioner. Oral preparations have significantly lower bioavailability. Must be administered under medical supervision.

Cycling: Typically continuous during and after cancer treatment. Seasonal adjustment in some protocols.

Cautions: Requires medical supervision. Raw plant is toxic. Subcutaneous injection site reactions common (expected). Avoid IV administration without oncology oversight. Drug interactions with immunosuppressants.

Modified Citrus Pectin (MCP)

Key Compounds: Low-molecular-weight galactose-rich pectin fragments

Mechanism: MCP binds to galectin-3 — a protein overexpressed in cancer cells that promotes tumor cell adhesion, metastasis, and immune evasion. By blocking galectin-3, MCP reduces metastatic potential, supports immune recognition of tumor cells, and demonstrates heavy metal chelation (especially lead, mercury, arsenic) in clinical trials.

Applications: Cancer metastasis prevention (adjunct), galectin-3 modulation, heavy metal detox, prostate cancer PSA support, cardiovascular fibrosis.

Dosing: PectaSol-C (clinically studied form): 15g/day in divided doses (cancer protocol). Maintenance/detox: 5g/day. Mix in water or juice.

Cycling: Continuous use appropriate in oncology context. Detox use: 3-month cycles.

Cautions: Very well tolerated. GI gas possible initially — titrate up. Ensure modified (low-MW) form; standard pectin does not have the same bioavailability or galectin-3 binding capacity.

• Foundational immune stack: Astragalus + Turkey Tail + Reishi — broad immune surveillance, NK cell activation, microbiome support
• Cancer adjunct stack: Turkey Tail + Mistletoe (injectable) + MCP — triple mechanism: immune activation, apoptosis, anti-metastasis
• Between-chemo recovery: Astragalus + Reishi + Triphala — rebuild immune function and microbiome between cytotoxic cycles
• Timing rule: Discuss all immune-stimulating botanicals with oncologist before use during active chemotherapy — some interactions are beneficial, others are contraindicated depending on agent
• Quality imperative: Medicinal mushrooms require dual-extraction (hot water + ethanol) for full beta-glucan and triterpene activity — mycelium-on-grain products are significantly inferior

Disclaimer

This reference is for educational purposes only and does not constitute medical advice. Anti-cancer botanicals are integrative adjuncts only — never replacements for conventional oncology care. Always disclose all supplements to your treating oncologist. Not intended to diagnose, treat, cure, or prevent any disease.